$NSTS
NSTS Bancorp, Inc. Stock $nsts

$nsts Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000143774923014235 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$69.00K	$64.00K
YoY Change	-95.42%	-95.06%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$60.00K	$65.00K
YoY Change	-9.09%	-1.52%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$269.0K	$221.0K
YoY Change	40.84%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$91.00K	$142.0K
YoY Change	-148.15%	-140.0%
Income Tax	$35.00K	-$28.00K
% Of Pretax Income		-19.72%
Net Earnings	-$126.0K	$170.0K
YoY Change	-184.56%	-160.93%
Net Earnings / Revenue	-182.61%	265.63%
Basic Earnings Per Share	-$0.03	$0.03
Diluted Earnings Per Share	-$0.03	$0.03
COMMON SHARES
Basic Shares Outstanding	5.349M	5.398M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$11.26M	$9.855M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$4.911M	$4.970M
YoY Change	-4.71%	-1.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$256.9M	$259.6M
YoY Change	-6.34%	-8.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$3.300M	$3.441M
YoY Change	10.59%	9.59%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.300M	$3.441M
YoY Change	10.59%	9.59%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.300M	$3.441M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$176.8M	$177.5M
YoY Change	-7.32%	-10.49%
SHAREHOLDERS EQUITY
Retained Earnings	$45.06M	$45.18M
YoY Change	-0.17%	0.44%
Common Stock	$56.00K	$54.00K
YoY Change	3.7%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$80.08M	$82.07M
YoY Change
Total Liabilities & Shareholders Equity	$256.9M	$259.6M
YoY Change	-6.34%	-8.9%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$126.0K	$170.0K
YoY Change	-184.56%	-160.93%
Depreciation, Depletion And Amortization	$60.00K	$65.00K
YoY Change	-9.09%	-1.52%
Cash From Operating Activities	-$120.0K	$263.0K
YoY Change	-475.0%	-84.19%
INVESTING ACTIVITIES
Capital Expenditures	$10.00K	$0.00
YoY Change	-106.45%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$2.730M	$2.362M
YoY Change	-124.35%	-111.88%
Cash From Investing Activities	$2.720M	$2.362M
YoY Change	-123.93%	-111.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.190M	-$5.917M
YoY Change	-83.9%	-88.58%
NET CHANGE
Cash From Operating Activities	-120.0K	$263.0K
Cash From Investing Activities	2.720M	$2.362M
Cash From Financing Activities	-1.190M	-$5.917M
Net Change In Cash	1.410M	-$3.292M
YoY Change	-107.53%	-95.3%
FREE CASH FLOW
Cash From Operating Activities	-$120.0K	$263.0K
Capital Expenditures	$10.00K	$0.00
Free Cash Flow	-$130.0K	$263.0K
YoY Change	-169.52%	-83.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5397959
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5397959
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5397959
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5397959
CY2023Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	0	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	2500000	usd
CY2022Q1	nsts	Shares Purchased During Period Shares Esop SharesPurchasedDuringPeriodSharesEsop	431836
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2022Q4	us-gaap	Other Real Estate OtherRealEstate	0	usd
CY2023Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.09	pure
CY2022Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.09	pure
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41232
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2522769
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	700 S. Lewis Ave
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Waukegan
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	IL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	60085
CY2023Q1	dei	City Area Code CityAreaCode	847
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	336-4430
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock
CY2023Q1	dei	Trading Symbol TradingSymbol	NSTS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5348902
CY2023Q1	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1146000	usd
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	1583000	usd
CY2023Q1	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	8709000	usd
CY2022Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	11564000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9855000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13147000	usd
CY2023Q1	nsts	Time Deposits With Other Financial Institution TimeDepositsWithOtherFinancialInstitution	3730000	usd
CY2022Q4	nsts	Time Deposits With Other Financial Institution TimeDepositsWithOtherFinancialInstitution	4477000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	121127000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	121205000	usd
CY2023Q1	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	550000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	550000	usd
CY2023Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	104522000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	103983000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	979000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	624000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	103543000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	103359000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4970000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5035000	usd
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	814000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	852000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	9295000	usd
CY2022Q4	us-gaap	Bank Owned Life Insurance BankOwnedLifeInsurance	9249000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	5676000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	6332000	usd
CY2023Q1	us-gaap	Assets Assets	259560000	usd
CY2022Q4	us-gaap	Assets Assets	264206000	usd
CY2023Q1	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	14759000	usd
CY2022Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	12977000	usd
CY2023Q1	nsts	Demand Deposit Accounts And Negotiable Order Of Withdrawal Now DemandDepositAccountsAndNegotiableOrderOfWithdrawalNow	18176000	usd
CY2022Q4	nsts	Demand Deposit Accounts And Negotiable Order Of Withdrawal Now DemandDepositAccountsAndNegotiableOrderOfWithdrawalNow	18659000	usd
CY2023Q1	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	39970000	usd
CY2022Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	42624000	usd
CY2023Q1	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	47732000	usd
CY2022Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	49068000	usd
CY2023Q1	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	6950000	usd
CY2022Q4	us-gaap	Time Deposit Liability Above Us Insurance Limit TimeDepositLiabilityAboveUsInsuranceLimit	8801000	usd
CY2023Q1	us-gaap	Interest Bearing Domestic Deposit Other Time Deposit InterestBearingDomesticDepositOtherTimeDeposit	44665000	usd
CY2022Q4	us-gaap	Interest Bearing Domestic Deposit Other Time Deposit InterestBearingDomesticDepositOtherTimeDeposit	46585000	usd
CY2023Q1	us-gaap	Deposits Deposits	172252000	usd
CY2022Q4	us-gaap	Deposits Deposits	178714000	usd
CY2023Q1	nsts	Escrow Deposits Liabilities EscrowDepositsLiabilities	1798000	usd
CY2022Q4	nsts	Escrow Deposits Liabilities EscrowDepositsLiabilities	1253000	usd
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3441000	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3697000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	177491000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	183664000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	54000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	54000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50421000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	50420000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	45182000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	45291000	usd
CY2023Q1	nsts	Unearned Esop Shares Cost UnearnedEsopSharesCost	4044000	usd
CY2022Q4	nsts	Unearned Esop Shares Cost UnearnedEsopSharesCost	4098000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-9544000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-11125000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	82069000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	80542000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	259560000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	264206000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	1018000	usd
CY2022Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	843000	usd
CY2023Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	658000	usd
CY2022Q1	us-gaap	Interest Income Securities Taxable InterestIncomeSecuritiesTaxable	325000	usd
CY2023Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	102000	usd
CY2022Q1	us-gaap	Interest Income Securities Tax Exempt InterestIncomeSecuritiesTaxExempt	89000	usd
CY2023Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	52000	usd
CY2022Q1	us-gaap	Interest Income Federal Funds Sold InterestIncomeFederalFundsSold	29000	usd
CY2023Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	24000	usd
CY2022Q1	us-gaap	Interest Income Deposits With Financial Institutions InterestIncomeDepositsWithFinancialInstitutions	5000	usd
CY2023Q1	nsts	Income From Federal Home Loan Bank Stock IncomeFromFederalHomeLoanBankStock	4000	usd
CY2022Q1	nsts	Income From Federal Home Loan Bank Stock IncomeFromFederalHomeLoanBankStock	4000	usd
CY2023Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1858000	usd
CY2022Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1295000	usd
CY2023Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	221000	usd
CY2022Q1	us-gaap	Interest Expense Domestic Deposits InterestExpenseDomesticDeposits	191000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1637000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1104000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-28000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	1665000	usd
CY2022Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	1104000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	2000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	31000	usd
CY2023Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	16000	usd
CY2022Q1	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	11000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	785000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	64000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	71000	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	46000	usd
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	43000	usd
CY2023Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	19000	usd
CY2022Q1	us-gaap	Noninterest Income Other Operating Income NoninterestIncomeOtherOperatingIncome	32000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	147000	usd
CY2022Q1	us-gaap	Noninterest Income NoninterestIncome	188000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	928000	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	903000	usd
CY2023Q1	us-gaap	Occupancy Net OccupancyNet	166000	usd
CY2022Q1	us-gaap	Occupancy Net OccupancyNet	181000	usd
CY2023Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	161000	usd
CY2022Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	148000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	121000	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	133000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	24000	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	26000	usd
CY2023Q1	nsts	Supervisory Fees And Assessment SupervisoryFeesAndAssessment	35000	usd
CY2022Q1	nsts	Supervisory Fees And Assessment SupervisoryFeesAndAssessment	41000	usd
CY2023Q1	us-gaap	Loan Processing Fee LoanProcessingFee	21000	usd
CY2022Q1	us-gaap	Loan Processing Fee LoanProcessingFee	29000	usd
CY2023Q1	nsts	Deposit Expenses DepositExpenses	52000	usd
CY2022Q1	nsts	Deposit Expenses DepositExpenses	34000	usd
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	56000	usd
CY2022Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	54000	usd
CY2023Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	106000	usd
CY2022Q1	us-gaap	Other Noninterest Expense OtherNoninterestExpense	98000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	1670000	usd
CY2022Q1	us-gaap	Noninterest Expense NoninterestExpense	1647000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	142000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-355000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-28000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-76000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	170000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-279000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4989933
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3974386
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	170000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-279000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2212000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-6243000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	631000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-1780000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1581000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4463000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1751000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-4742000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	45183000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-279000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49440000	usd
CY2022Q1	nsts	Stock Issued During Period Value Donation StockIssuedDuringPeriodValueDonation	1009000	usd
CY2022Q1	nsts	Shares Purchased During Period Value Esop SharesPurchasedDuringPeriodValueESOP	-4319000	usd
CY2022Q1	nsts	Esop Shares Committed To Be Released ESOPSharesCommittedToBeReleased	54000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-4463000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	86625000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	80542000	usd
CY2023Q1	nsts	Stock Issued During Period Value Donation StockIssuedDuringPeriodValueDonation	170000	usd
CY2023Q1	nsts	Esop Shares Committed To Be Released ESOPSharesCommittedToBeReleased	55000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	1581000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	82069000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	170000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-279000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	65000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	66000	usd
CY2023Q1	nsts	Securities Amortization And Accretion Net SecuritiesAmortizationAndAccretionNet	135000	usd
CY2022Q1	nsts	Securities Amortization And Accretion Net SecuritiesAmortizationAndAccretionNet	314000	usd
CY2023Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	585000	usd
CY2022Q1	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	3785000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	587000	usd
CY2022Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	3745000	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	2000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Mortgage Loans GainLossOnSaleOfMortgageLoans	31000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	-28000	usd
CY2022Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	0	usd
CY2023Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	46000	usd
CY2022Q1	us-gaap	Bank Owned Life Insurance Income BankOwnedLifeInsuranceIncome	43000	usd
CY2023Q1	nsts	Issuance Of Shares For Donation IssuanceOfSharesForDonation	0	usd
CY2022Q1	nsts	Issuance Of Shares For Donation IssuanceOfSharesForDonation	1009000	usd
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	55000	usd
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	54000	usd
CY2023Q1	nsts	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	-173000	usd
CY2022Q1	nsts	Increase Decrease In Accrued Interest Receivable And Other Assets IncreaseDecreaseInAccruedInterestReceivableAndOtherAssets	-1096000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-261000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-483000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	263000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1663000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	540000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Loans Receivable PaymentsForProceedsFromLoansReceivable	811000	usd
CY2023Q1	nsts	Principal Repayments On Mortgage Backed Securities PrincipalRepaymentsOnMortgageBackedSecurities	-2155000	usd
CY2022Q1	nsts	Principal Repayments On Mortgage Backed Securities PrincipalRepaymentsOnMortgageBackedSecurities	-5249000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	25281000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS	0	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Mortgage Backed Securities Mbs ProceedsFromMaturitiesPrepaymentsAndCallsOfMortgageBackedSecuritiesMBS	970000	usd
CY2023Q1	nsts	Proceeds From Payments For In Time Deposits Other Financial Instrument Net ProceedsFromPaymentsForInTimeDepositsOtherFinancialInstrumentNet	747000	usd
CY2022Q1	nsts	Proceeds From Payments For In Time Deposits Other Financial Instrument Net ProceedsFromPaymentsForInTimeDepositsOtherFinancialInstrumentNet	-9000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2362000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19926000	usd
CY2023Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-6462000	usd
CY2022Q1	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-97469000	usd
CY2023Q1	nsts	Net Change In Escrow Deposits NetChangeInEscrowDeposits	545000	usd
CY2022Q1	nsts	Net Change In Escrow Deposits NetChangeInEscrowDeposits	552000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49440000	usd
CY2023Q1	us-gaap	Origination Of Loans To Employee Stock Ownership Plans OriginationOfLoansToEmployeeStockOwnershipPlans	-0	usd
CY2022Q1	us-gaap	Origination Of Loans To Employee Stock Ownership Plans OriginationOfLoansToEmployeeStockOwnershipPlans	4319000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5917000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-51796000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-3292000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-70059000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13147000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	121611000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9855000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	51552000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	221000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	286000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	624000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	0	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5453000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	58285000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	41909000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	15480000	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	121127000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	62000	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	13410000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	134475000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	3968000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	64602000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	38421000	usd
CY2022Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	14214000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	121205000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	15566000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	136765000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	39753000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	1933000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	78070000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	11477000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	117823000	usd
CY2023Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	13410000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	77199000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	7432000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	43229000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	8134000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	120428000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	15566000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	103509000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	102991000	usd
CY2023Q1	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	1013000	usd
CY2022Q4	us-gaap	Financing Receivable Unamortized Loan Commitment Origination Fee And Premium Discount FinancingReceivableUnamortizedLoanCommitmentOriginationFeeAndPremiumDiscount	992000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	979000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	624000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	103543000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	103359000	usd
CY2023Q1	us-gaap	Escrow Deposit EscrowDeposit	300000	usd
CY2022Q4	us-gaap	Escrow Deposit EscrowDeposit	231000	usd
CY2023Q1	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	587000	usd
CY2022Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	597000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	624000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	-0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	-0	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-29000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	979000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	779000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	-0	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	6000	usd
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Loss Writeoff After Recovery FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery	-6000	usd
CY2023Q1	us-gaap	Off Balance Sheet Credit Loss Liability OffBalanceSheetCreditLossLiability	6000	usd
CY2023Q1	us-gaap	Financing Receivable Originated In Current Fiscal Year FinancingReceivableOriginatedInCurrentFiscalYear	2244000	usd
CY2023Q1	us-gaap	Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear	20653000	usd
CY2023Q1	us-gaap	Financing Receivable Originated Two Years Before Latest Fiscal Year FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear	21379000	usd
CY2023Q1	nsts	Financing Receivable Originated More Than Three Years Before Current Fiscal Year FinancingReceivableOriginatedMoreThanThreeYearsBeforeCurrentFiscalYear	58043000	usd
CY2023Q1	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	1191000	usd
CY2023Q1	us-gaap	Financing Receivable Revolving Converted To Term Loan FinancingReceivableRevolvingConvertedToTermLoan	0	usd
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	103509000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	102991000	usd
CY2023Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	148000	usd
CY2023Q1	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	103509000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	154000	usd
CY2022Q4	us-gaap	Financing Receivable Before Allowance For Credit Loss And Fee FinancingReceivableBeforeAllowanceForCreditLossAndFee	102991000	usd
CY2023Q1	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	148000	usd
CY2023Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	148000	usd
CY2022Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	154000	usd
CY2023Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2022Q1	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	0	usd
CY2023Q1	us-gaap	Other Real Estate OtherRealEstate	0	usd
CY2022Q4	us-gaap	Mortgage Loans In Process Of Foreclosure Amount MortgageLoansInProcessOfForeclosureAmount	0	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	29263000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	13072000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	4074000	usd
CY2023Q1	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	2287000	usd
CY2023Q1	nsts	Time Deposit Maturities Year Four And Beyond TimeDepositMaturitiesYearFourAndBeyond	2919000	usd
CY2023Q1	us-gaap	Time Deposits TimeDeposits	51615000	usd
CY2023Q1	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable	69800000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Maximum Amount Available FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresMaximumAmountAvailable	68600000	usd
CY2023Q1	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1 FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1	88100000	usd
CY2022Q4	us-gaap	Federal Home Loan Bank Advances General Debt Obligations Disclosures Collateral Pledged1 FederalHomeLoanBankAdvancesGeneralDebtObligationsDisclosuresCollateralPledged1	86600000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q1	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	65677000	usd
CY2023Q1	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.2526	pure
CY2023Q1	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	23400000	usd
CY2022Q4	us-gaap	Tier One Leverage Capital TierOneLeverageCapital	65634000	usd
CY2022Q4	us-gaap	Tier One Leverage Capital To Average Assets TierOneLeverageCapitalToAverageAssets	0.2481	pure
CY2022Q4	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized TierOneLeverageCapitalRequiredToBeWellCapitalized	23809000	usd
CY2023Q1	us-gaap	Other Commitment OtherCommitment	4855000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	3665000	usd
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	170000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-279000	usd
CY2023Q1	nsts	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	5397959
CY2022Q1	nsts	Weighted Average Common Shares Outstanding WeightedAverageCommonSharesOutstanding	4318367
CY2023Q1	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	408026
CY2022Q1	us-gaap	Weighted Average Number Of Shares Employee Stock Ownership Plan Shares Not Committed To Be Released WeightedAverageNumberOfSharesEmployeeStockOwnershipPlanSharesNotCommittedToBeReleased	343981
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	4989933
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	3974386
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	431836
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased	10
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Shares Contributed To Esop EmployeeStockOwnershipPlanESOPSharesContributedToESOP	0
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	55000	usd
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Compensation Expense EmployeeStockOwnershipPlanESOPCompensationExpense	54000	usd
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	22009
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Allocated Shares EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares	0
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares	5404
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares	4320
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	404423
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Number Of Suspense Shares EmployeeStockOwnershipPlanESOPNumberOfSuspenseShares	427516
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	431836
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	431836
CY2023Q1	us-gaap	Employee Stock Ownership Plan Esop Deferred Shares Fair Value EmployeeStockOwnershipPlanESOPDeferredSharesFairValue	3676000	usd
CY2022Q1	us-gaap	Employee Stock Ownership Plan Esop Deferred Shares Fair Value EmployeeStockOwnershipPlanESOPDeferredSharesFairValue	5164000	usd
CY2023Q1	us-gaap	Share Price SharePrice	9.09
CY2022Q1	us-gaap	Share Price SharePrice	12.08

Files In Submission

Name	View Source	Status
nsts20230404_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
0001437749-23-014235-index-headers.html	Edgar Link	pending
0001437749-23-014235-index.html	Edgar Link	pending
0001437749-23-014235.txt	Edgar Link	pending
0001437749-23-014235-xbrl.zip	Edgar Link	pending
ex_497095.htm	Edgar Link	pending
ex_497096.htm	Edgar Link	pending
ex_497097.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nsts-20230331.xsd	Edgar Link	pending
nsts20230404_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
nsts-20230331_cal.xml	Edgar Link	unprocessable
nsts-20230331_def.xml	Edgar Link	unprocessable
nsts-20230331_lab.xml	Edgar Link	unprocessable
nsts-20230331_pre.xml	Edgar Link	unprocessable
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NSTS
NSTS Bancorp, Inc. Stock $nsts

2023 Q2 Form 10-Q Financial Statement

#000143774923014235 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NSTS NSTS Bancorp, Inc. Stock $nsts

2023 Q2 Form 10-Q Financial Statement

#000143774923014235 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NSTS
NSTS Bancorp, Inc. Stock $nsts